Lindsay Frerichs, MD

Brad A. Racette, MD, FAAN, is the Kemper and Ethel Marley Professor and Chair of Neurology at Barrow Neurological Institute. He is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Racette’s clinical expertise includes the diagnosis and management of all types of movement disorders, and he has a special expertise in the use of botulinum toxin for limb disorders. He is a fellow of the American Academy of Neurology and the American Neurological Association. He is the past chairman of the Neurological, Aging, and Musculoskeletal Epidemiology Study Section at the National Institutes of Health (NIH) and a current member of the National Advisory Environmental Health Sciences Council for the National Institute of Environmental Health Sciences. He has served as an advisor for numerous international regulatory agencies. He is an honorary professor of public health at the University of Witwatersrand in Johannesburg, South Africa, and a professor emeritus at Washington University. Dr. Racette earned his medical degree from the Feinberg School of Medicine at Northwestern University in Chicago and his bachelor’s degree in molecular biology from Princeton University in New Jersey. He completed his neurology residency and a fellowship in movement disorders at Washington University School of Medicine in St. Louis. He then joined the faculty at Washington University, where he held the roles of Robert Allan Finke professor of neurology and executive vice-chairman of neurology. Dr. Racette’s research focuses on manganese neurotoxicity, environmental risk factors for Parkinson’s disease, and administrative data studies of Parkinson’s disease and other neurologic diseases. He has authored over 160 peer-reviewed publications. He is supported by the NIH, Michael J. Fox Foundation, Department of Defense, Cure Alzheimer’s Fund, Northeast ALS Consortium, and American Parkinson Disease Association.

Anna Burke, MD, is a geriatric psychiatrist and the director of neuropsychiatry at Barrow Neurological Institute. She is board certified in psychiatry with a subspecialty certification in geriatric psychiatry by the American Board of Psychiatry and Neurology. Dr. Burke’s expertise includes the treatment of challenging behavioral and psychiatric disturbances that result from neurological conditions. She is a member of the American Association for Geriatric Psychiatry, the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment, and the Arizona Geriatrics Society. Dr. Burke received her medical degree from Gdańsk Medical University. She completed her residency training in adult psychiatry at Hartford Hospital’s Institute of Living before completing a geriatric psychiatry fellowship at McLean Hospital, the largest psychiatric teaching hospital of Harvard Medical School. In addition to her clinical work, Dr. Burke has led numerous clinical trials of investigational drugs, neuromodulation, environmental modifications, prevention methods, and novel neuroimaging techniques for cognitively impaired patients with neurodegenerative disorders.